Correlation Between Protalix Biotherapeutics and Atossa Genetics

Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Atossa Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Atossa Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protalix Biotherapeutics and Atossa Genetics, you can compare the effects of market volatilities on Protalix Biotherapeutics and Atossa Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Atossa Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Atossa Genetics.

Diversification Opportunities for Protalix Biotherapeutics and Atossa Genetics

0.16

Correlation Coefficient

Protalix Biotherapeutics  Atossa Genetics

Average diversification

The 3 months correlation between Protalix and Atossa is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Atossa Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atossa Genetics and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Atossa Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atossa Genetics has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Atossa Genetics go up and down completely randomly.

Pair Corralation between Protalix Biotherapeutics and Atossa Genetics

Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 0.96 times more return on investment than Atossa Genetics. However, Protalix Biotherapeutics is 1.04 times less risky than Atossa Genetics. It trades about 0.01 of its potential returns per unit of risk. Atossa Genetics is currently generating about -0.07 per unit of risk. If you would invest  167.00  in Protalix Biotherapeutics on May 16, 2025 and sell it today you would lose (3.00) from holding Protalix Biotherapeutics or give up 1.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Protalix Biotherapeutics  vs.  Atossa Genetics

Protalix Biotherapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Protalix Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Protalix Biotherapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Atossa Genetics

Risk-Adjusted Performance

Weakest

Over the last 90 days Atossa Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in September 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Protalix Biotherapeutics and Atossa Genetics

The main advantage of trading using opposite Protalix Biotherapeutics and Atossa Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Atossa Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atossa Genetics will offset losses from the drop in Atossa Genetics' long position.

The idea behind Protalix Biotherapeutics and Atossa Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..